Credit Suisse’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-31,974
| Closed | -$43K | – | 3700 |
|
|
2021
Q3 | $43K | Sell |
31,974
-33,951
| -51% | -$45.7K | ﹤0.01% | 3484 |
|
|
2021
Q2 | $126K | Buy |
65,925
+55,925
| +559% | +$107K | ﹤0.01% | 3489 |
|
|
2021
Q1 | $45K | Buy |
+10,000
| New | +$45K | ﹤0.01% | 3370 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$38K | – | 3289 |
|
|
2020
Q2 | $38K | Buy |
+10,000
| New | +$38K | ﹤0.01% | 3237 |
|